SCHEMBL2297091

SCHEMBL2297091

CCOC(=O)c1c(-c2ccc(Oc3ccc(F)cc3)cc2)oc2cc(NS(=O)(=O)CCS(C)(=O)=O)c(C3CC3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.45
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
MAPT P10636 6/20 0.41
TP53 P04637 4/20 0.41
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KCNH2 Q12809 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RCE1 Q9Y256 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18095501 0.89 CYP2C9 (0.44) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL2295394 0.88 ALOX5 (0.52) PTGS2MEN1KMT2AMAPTTP53
SCHEMBL6120029 0.88 MAPT (0.43) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL9952934 0.87 CYP2C9 (0.46) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL15455978 0.87 MAPT (0.42) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL2297048 0.83 PTGS2 (0.53) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL6119862 0.82 MAPT (0.43) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL2297094 0.81 CYP2C9 (0.53) PTGS2MEN1KMT2ACYP3A4CYP2C9
SCHEMBL6119409 0.81 MAPT (0.42) PTGS2MEN1KMT2AMAPTTP53
SCHEMBL14697648 0.81 ALOX5 (0.45) MEN1KMT2ACYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012067663-A1 COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-05-24 WO disclosed
WO-2011103063-A1 THERAPEUTIC COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-08-25 WO disclosed